Mike

Hi Mike,

This is not about cost or price problems. I afraid that Dopamine agonists will be resistance and not work a long time if  I start dopamine agonists. 1-1.5 year later, I will need carbidopa/levadopa support.

Hi Cemal,

I have patients who have been on DA therapy much longer than 1-2 years without needing the addition of LD/CD, so…[Read more]

Hi Cemal,

Here in the UK we rarely use Amantadine as a single therapy for Parkinson’s. It is more often used to reduce the impact of longer term levodopa side effects, especially dyskinesias. In terms of symptom control, it can be useful, but would lack the efficacy of levodopa, or dopamine agonist therapy.

Can I ask why you have not been given…[Read more]